| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_41f3512accd7696fcf24a897996ffc33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d726920841a53b211359de45c50b83d6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_835db48394c2627b656c978092d117ea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a5ffa3f9d6b87e15e0a1551fb129b531 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-663
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-167 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-663
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-167 |
| filingDate |
2003-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93e981ba57283d0466147709c6d64ec7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c581130055b3958daf149aedd75d7754
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c2658c97474dbf5190ebcce44de3953 |
| publicationDate |
2003-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-03094925-A1 |
| titleOfInvention |
Injectable bisphosphonate formulations |
| abstract |
The present invention relates to a pharmaceutical composition in the form of an aqueous solution having a pH value within the range of from 3.5 to 5.5, comprising an alkaline salt of a bisphosphonic acid and lidocaine hydrochloride at a concentration within the range of from 0.5 to 2.0% (w/v). The composition is particularly suitable for intramuscular administration. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006012700-A1 |
| priorityDate |
2002-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |